Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 25, 2018 - Issue 1
Submit an article Journal homepage
372
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis

Parameswaran HariDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; View further author information
,
Huamao Mark LinMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8399-8966View further author information
ORCID Icon,
Carl V. AscheCenter for Outcomes Research, Department of Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA; ;Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; View further author information
,
Jinma RenCenter for Outcomes Research, Department of Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA; ORCID Iconhttps://orcid.org/0000-0002-4616-476XView further author information
ORCID Icon,
Candice YongMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information
,
Katarina LuptakovaMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information
,
Douglas V. FallerMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information
&
Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USAORCID Iconhttp://orcid.org/0000-0002-6307-2445View further author information
ORCID Icon show all
Pages 1-7 | Received 20 Jul 2017, Accepted 24 Nov 2017, Published online: 05 Jan 2018

References

  • Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–596.
  • Kyle RA, Linos A, Beard CM, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992;79:1817–1822.
  • Merlini G, Wechalekar AD, Palladini G. Systemic light chain amyloidosis: an update for treating physicians. Blood. 2013;121:5124–5130.
  • Lin HM, Gao X, Cooke CE, et al. Disease burden of systemic light-chain amyloidosis: a systematic literature review. Curr Med Res Opin. 2017;33:1017–1033.
  • Wechalekar AD, Gillmore JD, Bird J, et al. Guidelines on the management of AL amyloidosis [Practice Guideline]. Br J Haematol. 2015;168:186–206.
  • NCCN clinical practice guidelines in oncology (NCCN Guidelines®) systemic light china amyloidosis: NCCN; Version 1.2017; 2017. Available from: http://www.richclinics.com/upload/201702/15/201702150926197085.pdf
  • Gertz MA, Lacy MQ, Dispenzieri A, et al. Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response. Haematologica. 2007;92:1415–1418.
  • Mikhael JR, Schuster SR, Jimenez-Zepeda VH, et al. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. Blood. 2012;119:4391–4394.
  • Kane RC, Bross PF, Farrell AT, et al. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy [Review]. Oncologist. 2003;8:508–513.
  • Gertz MA. Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment. Am J Hematol. 2016;91:947–956.
  • Zhao Q, Li F, Song P, et al. Clinical characteristics and treatment outcome of Chinese patients with systemic amyloid light-chain amyloidosis: a retrospective single-center analysis. Clin Lymphom Myeloma Leuk. 2016;16:104–110.
  • D'Souza A, Dispenzieri A, Wirk B, et al. Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for international blood and marrow transplant research study. J Clin Oncol. 2015;33:3741–3749.
  • Kumar SK, Gertz MA, Lacy MQ, et al. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc. 2011;86:12–18.
  • Weber N, Mollee P, Augustson B, et al. Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group [Review]. Intern Med J. 2015;45:371–382.
  • Devine SM. Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis. Biology Blood Marrow Transplant. 2014;20:14–19.
  • Wang G, Zhang Z, Ayala C, et al. Costs of heart failure-related hospitalizations in patients aged 18 to 64 years. Am J Manag Care. 2010;16:769–776.
  • Unroe KT, Greiner MA, Hernandez AF, et al. Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med. 2011;171:196–203.
  • Hynes DM, Stroupe KT, Fischer MJ, et al. Comparing VA and private sector healthcare costs for end-stage renal disease. Med Care. 2012;50:161–170.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.